ARCHIVES

Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements.

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Cost Of Cancer:$40 Billion In 1980, Now Probably Between $50-80 Billion; “The Tip Of The Iceberg”

February 25, 1983

Cancer Letter On Vacation

August 3, 1984

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011